# Näky reviews (2026): GLP-1 telehealth sellers | This GLP The rate on each injection card is the six-month plan, not the monthly one. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/naky Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 A panel hides the monthly # Näky review The rate on each injection card is the six-month plan, not the monthly one. ## The verdict Näky's compounded semaglutide and tirzepatide cards both advertise a rate a buyer reaches only by paying for six months at once. The month-to-month figures of $185 and $295 sit inside a pricing panel that stays shut until you open it. The daily drops are the honest exception, because $145 is the only plan they have. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Dose pricing Flat across doses Injection From $185/mo Oral From $145/mo Dose published No Prescription Required Compounded Yes — not FDA-approved Pharmacy Not named Näky sells compounded semaglutide and compounded tirzepatide as weekly injections, a daily semaglutide drop taken under the tongue, and a branded oral semaglutide pill, with a separate microdosing line and a longevity line running NAD+ and sermorelin alongside them. The trading entity names itself on the product pages and states that it is not affiliated with the manufacturer whose brands it references. 1. ## Who writes the prescription, and what do they see? A licensed provider reviews the free medical intake before anything is charged, and the site is explicit that a patient pays only if a prescription is written. Someone arriving already on a GLP-1 is asked for their current dose during intake, so the provider can continue it rather than start them over. Most sellers leave that to a support ticket after the first vial has already arrived. Each injection is sold as a one, three or six month plan, and the longer the plan the lower the monthly figure, with the six-month rate being the one the card advertises. The drops are sold monthly and only monthly. Shipping is free and stated as two-day, the pharmacies are described as United States based and FDA-regulated rather than named, and the trust bar running across every page promises the same price at every dose. 2. ## What happens when the dose goes up? Näky states that the price holds at every dose, so the ladder itself costs nothing extra, and a new patient is started on a low dose to ease the first weeks. A transferring patient keeps their existing dose rather than dropping back to the bottom. What the site does not publish is a milligram figure against any plan, or who signs off on the step from one dose to the next. 3. ## What the price includes The semaglutide injection is $185 a month and the tirzepatide injection is $295, and neither number appears on the card a reader lands on. Both sit behind a collapsed panel headed Pricing Details, while the card above it quotes the six-month rate. Three-month plans sit between the two, and the daily drops carry one plan at $145 with no ladder behind it, which means the drops and the six-month injection rung meet at the same figure from opposite directions. 4. ## What it claims, and what it cites Both injections are compounded rather than manufactured, and the page states that compounded [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) is not FDA-approved and that the agency does not evaluate compounded products for safety, effectiveness or quality. A branded oral pill is sold alongside them. No compounding pharmacy is named anywhere on the site. ## Where it holds up, and where it does not - Strength: The whole plan ladder is published, once the panel is opened - Strength: One price at every dose is stated across the site - Strength: A transferring patient keeps their current dose - Strength: Nothing is charged unless a prescription is written - Strength: Free two-day shipping is included - Limitation: Each injection card quotes the six-month rate as its headline - Limitation: The month-to-month figures sit inside a collapsed panel - Limitation: No compounding pharmacy is named - Limitation: No milligram dose is published against any plan ## What the evidence says about this kind of treatment The assessment above is about Näky. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who opens the pricing panel before deciding what a headline rate means. Wrong for A buyer who wants the month-to-month figure on the first screen they see. ## The evidence behind what Näky prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Näky compares | Seller | Who it suits | Go | | --- | --- | --- | | SnagRx | Buyers who want to stay month to month without paying much for it | | | HealthRX | Buyers who expect to escalate and want the later months priced | | | DreamHug Medical | A reader signing for the longest term who needs a broad list of served states | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [LaSara Medical Group](https://thisglp.com/reviews/lasara) [Lavender Sky Health](https://thisglp.com/reviews/lavender-sky-health) [Layla](https://thisglp.com/reviews/layla) [Lean Meds](https://thisglp.com/reviews/leanmeds) [Lean Rx](https://thisglp.com/reviews/lean-rx) [LeanDose](https://thisglp.com/reviews/leandose) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $145 a month what a new semaglutide patient pays? Only on the six-month plan. The one-month supply is $185, and the three-month plan sits between the two. Do the drops have a multi-month discount? No. The oral semaglutide drops are sold as a single one-month plan at $145, with no longer term offered. Does the price rise as the dose goes up? Näky states the same price applies at every dose, and repeats that promise in the bar running across every page. Is Näky expensive compared with other GLP-1 telehealth sellers? Näky publishes a starting figure of $145/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Näky below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).